Delivery Order SPE2DB22D3016-SPE2DB25FBFC6
- Not listed
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $9,248.01 to AmerisourceBergen Drug Corp for Benlysta 200 mg/ml auto-injector pharmaceutical supplies. The award was made on August 1, 2025, with an ultimate completion date of August 22, 2025. This non-set-aside, competitively awarded contract utilizes firm fixed pricing and represents a child delivery order under AmerisourceBergen's larger indefinite delivery vehicle with DLA. The place of performance is located in...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $3,082.67 to AmerisourceBergen Drug Corp for the supply of Benlysta 200 mg/ml auto-injectors. This competitively awarded, non-set-aside contract was finalized on July 31, 2025, with an ultimate completion date of August 21, 2025. The pharmaceutical product will be delivered to the place of performance in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate headquarters. The contract utilizes firm fixed...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 15, 2025, for the supply of Benlysta 200 mg/ml auto-injectors, with a contract ceiling value of $6,165.34 and an ultimate completion date of September 8, 2025. This competitive award, which carries no set-aside designation, is structured as a firm fixed-price delivery order and reflects the continuation of pharmaceutical supply services to federal military and healthcare systems. The place of...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 28, 2025, for the supply of Benlysta 200 mg/mL auto-injector with a ceiling value of $3,082.67. This competitively awarded, non-set-aside contract utilizes firm fixed pricing and is scheduled for completion by August 18, 2025. The work will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, with the company serving as the prime contractor on this delivery...
- The Defense Logistics Agency awarded a $12,330.68 firm fixed-price delivery order to AmerisourceBergen Drug Corp for Benlysta 200 mg/mL auto-injector supplies, with a completion date of October 3, 2025. This non-set-aside contract represents a competitive award to the pharmaceutical distributor for pharmaceutical products supporting federal medical procurement needs. The work will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order...
- The Defense Logistics Agency awarded a delivery order valued at $15,777.72 to AmerisourceBergen Drug Corp for the supply of Benlysta 400 mg vials. This contract, issued on August 21, 2025, with an ultimate completion date of September 12, 2025, is a firm fixed-price delivery order with no set-aside designation. The award was made competitively and represents a specific fulfillment requirement under AmerisourceBergen's larger federal contract vehicle supporting military healthcare procurement....
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 21, 2025, for the supply of Benlysta 200 mg/mL auto-injector, valued at $6,165.34. This is a firm fixed price, non-competitive delivery order with an ultimate completion date of September 12, 2025. The order is issued under AmerisourceBergen's existing Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), a $999.999 billion global pharmaceutical support vehicle running through...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 1, 2025, for Benlysta 200 mg/ml auto-injectors, a pharmaceutical product used in immunological treatments. This non-set-aside, competitively awarded delivery order has a ceiling value of $6,165.34 and a firm fixed price structure, with an ultimate completion date of August 22, 2025. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery...
- The Defense Logistics Agency awarded a $6,165.34 delivery order to AmerisourceBergen Drug Corp on September 4, 2025, for the supply of Benlysta 200 mg/ml auto-injector medication. This is a firm fixed price, non-set-aside contract with a completion date of September 25, 2025, and performance at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The delivery order falls under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX),...
- The Defense Logistics Agency has awarded a delivery order valued at $3,082.67 to AmerisourceBergen Drug Corp for the supply of Benlysta 200 mg/ml auto-injector medication. This competitively awarded, firm fixed price contract has an ultimate completion date of September 23, 2025, and represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026. The place of...
- SPE2DB22D3016Indefinite Delivery Contract
- SPE2DB22D3016-SPE2DB25FBFC6Delivery Order
The Defense Logistics Agency (DLA) awarded AmerisourceBergen Drug Corp a delivery order on August 15, 2025, valued at $12,330.68 for the supply of Benlysta 200 mg/ml auto-injector medication. This is a firm fixed price, non-set-aside delivery order with a completion deadline of September 8, 2025, and represents a child contract under AmerisourceBergen's larger federal contract vehicle with DLA. The pharmaceutical product will be delivered to the company's corporate office location in Conshohocken, Pennsylvania, supporting federal medical procurement needs. This delivery order operates under AmerisourceBergen Drug Corp's Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (designated SPE2DX), valued at $999,999,999.00 through December 2026. As a major pharmaceutical distributor, AmerisourceBergen has demonstrated consistent capability to fulfill federal medical supply requirements through open competition, with this order exemplifying the company's role as a critical vendor for military healthcare systems. The contract reflects the broader pharmaceutical supply chain support that DLA provides to the Defense Health Agency and other federal healthcare programs.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $12.3k | 8/15/25 |